Halting Nucleoside Analogues in Chronic Hepatitis B

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Chronic Hepatitis B
Interventions
OTHER

stopping nucleos(t)ide therapy

patients taking nucleoside(t)ide therapy will stop treatment

OTHER

Continue nucleos(t)ide analogue

Continue nucleos(t)ide analogue

Trial Locations (1)

119228

National University Hospital, Singapore

All Listed Sponsors
collaborator

Tan Tock Seng Hospital

OTHER

collaborator

Singapore General Hospital

OTHER

collaborator

Changi General Hospital

OTHER

lead

Seng Gee Lim

OTHER

NCT04102176 - Halting Nucleoside Analogues in Chronic Hepatitis B | Biotech Hunter | Biotech Hunter